5
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Elevated Peroxynitrite as the Cause of Chronic Fatigue Syndrome

Other Inducers and Mechanisms of Symptom Generation

Pages 45-58 | Published online: 04 Dec 2011

References

  • Pall ML. Elevated peroxynitrite as the cause of chronic fatigue syndrome. Medical Hypoth 2000; 54: 115–125.
  • Gebhard F, Ntissler AK, Misch M, et al. Early posttraumatic increase in pro-duction of nitric oxide in humans. Shock 2000; 10: 237–242.
  • Heresco Levy U, Javitt DC. The role of N-methyl-D-aspartate (NMDA) re-ceptor-mediated neurotranmission in the pathophysiology and therapeutics of psy-chiatric syndromes. Eur Neuropharmacol 1998; 8: 141–152.
  • McEwen BS. Possible mechanisms for atrophy of the human hippocampus. Mol Psychiatry 1997; 2: 255–262.
  • Chambers RA, Bremner JD, Moghaddam B, et al. Glutamate and post-trau-matic stress disorder: toward a psychobiology of dissociation. Semin Clin Neuropsy-chiatry 1999; 4: 274–281.
  • Goldstein LE, Rasmussen AM, Bunney BS, et al. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefontal cortical monoamine re-sponses to psychological stress in the rat. J Neurosci 1996; 16: 4787–4798.
  • Lafon Cazal M, Culcasi M, Gaven F, et al. Nitric oxide, superoxide and perox-ynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 1993; 32: 1259–1266.
  • Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689–695.
  • Culcasi M, Lafon Cazal M, Pietri S, et al. Glutamate receptors induce a burst of superoxide via activation of superoxide synthase in arginine-depleted neurons. J Biol Chem 1994; 269: 12589–12593.
  • Lafon Cazal M, Pietri S, Culcasi M, et al. NMDA-dependent superoxide pro-duction and neurotoxicity. Nature 1993; 364: 535–537.
  • Bindokas VP, Jordan J, Lee CC, et al. Superoxide production in rat hippocam-pal neurons: selective imaging with hydroethidine. J Neurosci 1996; 16: 1324–1336.
  • Reynolds IJ, Hastings TG. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 1995; 15: 3318–3327.
  • Beckman JS. The double-edged role of nitric oxide in brain function and su-peroxide-mediated injury. J Dev Physiol 1991; 15: 53–59.
  • Alptekin N, Seckin S, Dogru Abbasoglu S, et al. Lipid peroxides, glutathione, gamma-glutamylcysteine synthetase and gamma-glutamyltranspeptidase activities in several tissue of rats following water-immersion stress. Phamacol Res 1996; 34: 167–169.
  • Seckin S, Alptekin N, Dogru Abbasoglu S, et al. The effect of chronic stress on hepatic and gastric lipid peroxidation in long-term depletion of glutathione in rats. Pharmacol Res 1997; 36: 55–57.
  • Konstandi M, Marselos M, Radon Camus AM, et al. The role of stress in regu-lation of drug metabolizing enzymes in mice. Eur J Drug Metab Phamacokinet 1998; 23: 483–490.
  • Carpman V. CF1DS treatment: the Cheney clinic's strategic approach. CF1DS Chronicle (Spring) 1995; 38–45.
  • Vanden Hoek TL, Becker LB, Shao Z, et al. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998; 273: 18092–18098.
  • Russell WJ, Jackson RM. Hydrogen peroxide release by mitochondria from normal and hypoxic lungs. Am J Med Sci 1994; 308: 239–243.
  • Smith DR, Stone D, Darley Usmar VM. Stimulation of mitochondrial oxygen consumption in isolated cardiomyocytes after hypoxia-reoxygenation. Free Radic Res 1996; 24: 159–166.
  • Jaeshcke H, Mitchell JR. Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochem Biophys Res Commun 1989; 160: 140–147.
  • McCord JM, Roy RS. The pathophysiology of superoxide: roles in inflamma-tion and ischemia. Can J Physiol Pharmacol 1982; 60: 1346–1352.
  • McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 150–163.
  • Rowe PC, Barron DF, Calkins H, et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos Syndrome. J Pediatr 1999; 135: 494–499.
  • Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycar-dia associated with norepinephrine-transporter deficiency. N Engl J Med 2000; 342: 541–549.
  • Rowe PC, Bou Holaigah I, Kan J, et al. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995; 345: 623–624.
  • Streeten DH, Anderson GH Jr: The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue syndrome. Clin Auton Res 1998; 8: 119–124.
  • Stewart JM, Gewitz MB, Weldon A, et al. Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue syndrome. J Pe-diatr 1999; 135: 218–225.
  • Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syn-drome. Am J Med 1998; 105: 15S–21S.
  • LaManca JJ, Peckerman A, Walker J, et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999; 19: 111–120.
  • SoRelle R. Nobel prize awarded to scientists for nitric oxide discoveries. Cir-culation 1998; 98: 2365–2366.
  • Howlett R. Nobel award stirs up debate in nitric oxide breakthrough. Nature 1998; 395: 625–626.
  • Williams N. NO news is good news-but only for three Americans. Science 1998; 282: 610–611.
  • Booke M, Meyer J, Lingnau W, et al. Use of nitric oxide synthase inhibitors in animal models of sepsis. New Horiz 1995; 3: 123–138.
  • Vallance P, Moncada S. Role of endogenous nitric oxide in septic shock. New Horiz 1993; 1: 77–86.
  • Avontuur JA, Bruining HA, Ince C. Sepsis and nitric oxide. Adv Exp Med Biol 1996; 388: 551–567.
  • Ketteler M, Cetto C, Kindorf M, et al. Nitric oxide in sepsis-syndrome: poten-tial treatment of septic shock by nitric oxide synthase antagonists. Kidney Int Suppl 1998; 64: S27–30.
  • Skloot F. The Night-Side: Chronic Fatigue Syndrome and the Illness Experi-ence. Brownsville, OR: Story Line Press, 1996.
  • Budgett R. Fatigue and underperformance in athletes: the overtraining syn-drome. Br J Sports Med, 1998; 32: 107–110.
  • Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a compre-hensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953–959.
  • Sheng WS, Lin JC, Apple F, et al. Brain energy stores in C57BL/6 mice after C. parvum injection. Neuroreport 1999; 10: 177–181.
  • Sahlin K. Metabolic factors in fatigue. Sports Med 1992; 13: 99–107.
  • Green HJ. Mechanisms of muscle fatigue in intense exercise. J Sports Sci 1997; 15: 247–256.
  • McLester JR, Jr. Muscle contraction and fatigue. The role of adenosine 5'-di-phosphate and inorganic phosphate. Sports Med 1997; 23: 287–305.
  • Bounos G, Molson J. Competition for glutathione precursors between the im-mune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome. Med Hypoth 1999; 53: 347–349.
  • Meydani SN, Wu D, Santos MS, et al. Antioxidants and immune response in aged persons: overview of present evidence. Am J Clin Nutr 1995; 62: 1462S–1476S.
  • Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Physiol 1996; 271: C1424–1437.
  • Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide and superoxide. Am J Physiol 1995; 268: L699–L722.
  • Richards RS, Roberts TK, Mathers D, et al. Investigation of erythrocyte oxi-dative damage in rheumatoid arthritis and chronic fatigue syndrome. J Chronic Fa-tigue Syndr 2000; 6: 37–46.
  • Moss RB, Mercandetti A, Vojdani A. TNF-11 and chronic fatigue syndrome. J Clin Immunol 1999; 19: 314–316.
  • Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunological abnormali-ties in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403–1410.
  • Caligiuri M, Murray C, Buchwald D, et al. Phenotypic and functional defi-ciency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139: 3306–3313.
  • Gupta S, Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 1991; 33: 319–327.
  • Ojo Amaize EA, Conley EJ, et al. Decreased natural killer cell activity is asso-ciated with severity of chronic fatigue immune dysfunction syndrome. Clin Infec Dis 1994; 18: S157–S159.
  • Barker E, Fujimura SF, Fadem MB, et al. Immunologic abnormalities associ-ated with chronic fatigue syndrome. Clin Infect Dis 1994; 18: S136–S141.
  • See DM, Cimoch P, Chou S, et al. The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells in patients with chronic fatigue syndrome. Integr Physiol Behav Sci 1998; 33: 280–287.
  • Salvucci O, Kolb JP, Dugas B, et al. The induction of nitric oxide by interleu-kin-12 and tumor necrosis factor-alpha in human natural killer cells: relationship with the regulation of lytic activity. J Clin Microbiol 1990; 28: 1403–1410.
  • Anbar M, Graft BM. Role of nitric oxide in the pathophysiology of pain. J Pain Symptom Manage 1997; 14: 225–254.
  • Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52: 127–136.
  • Tal M. A novel antioxidant alleviates heat hyperalgesia in rats with an experi-mental painful peripheral neuropathy. Neuroreport 1996; 7: 1382–1384.
  • Fozard JR. The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine? Arch Int Pharmacodyn Ther 1995; 329: 111–119.
  • Thomsen LL. Investigations into the role of nitric oxide and the large intracra-nial arteries in migraine headache. Cephalalgia 1997; 17: 873–895.
  • Sandman CA, Barron IL, Nackoul K, et al. Memory deficits associated with chronic fatigue immune dysfunction syndrome. Biol Psychiatry 1993; 33: 618–623.
  • Servatius RJ, Tapp WN, Bergen MT, et al. Impaired associative learning in chronic fatigue syndrome. Neuroreport 1998; 9: 1153–1157.
  • Joyce E, Blumenthal S, Wessely S. Memory, attention and executive function in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1996; 60: 495–503.
  • Michiels V. Cluydts R, Fischler B, et al. Cognitive functioning in patients with chronic fatigue syndrome. J Clin Exp Neuropsychol 1996; 18: 666–677.
  • Michiels V. Cluydts R, Fishler B. Attention and verbal learning in patients with chronic fatigue syndrome. J Int Neuropsychol Soc 1998; 4: 456–466.
  • Huang EP. Synaptic plasticity: a role for nitric oxide in LTP. Curr Biol 1997; 7: R141–R143.
  • Hawkins RD, Son H, Arancio 0. Nitric oxide as a retrograde messenger dur-ing long-term potentiation in hippocampus. Prog Brain Res 1998; 118: 115–172.
  • Holscher C. Nitric oxide, the enigmatic neuronal messenger: Its role in synap-tic plasticity. Trends Neurosci 1997; 20: 298–303.
  • Medina JH, Izquierdo I. Retrograde messengers, long-term potentiation and memory. Brain Res Brain Res Rev 1995; 21: 185–194.
  • Keller RH, Lane IL, Klimas N, et al. Association between }ILA class II anti-gens and the chronic fatigue immune dysfunction syndrome. Clin Infect Dis 1994; 18: S154–S156.
  • Pellegrino MJ, Waylonis GW, Sommer A. Familial occurrence of primary fi-bromylagia. Arch Phys Med Rehabil 1989; 70: 61–63.
  • Liaudet L, Gnaigi A, Rousselet A, et al. Effect of L-lysine on nitric oxide overproduction in endotoxic shock. Br J Pharmacol 1997; 122: 742–748.
  • Cymeryng CB, Dada LA, Colonna C, et al. The effects of L-arginine in rat adrenal cells: involvement of nitric oxide synthase. Endocrinology 1999; 140: 2962–2967.
  • Kleinert S. The hygeine hypothesis gains further momentum in childhood asthma. Lancet 2000; 355: 1795.
  • Bell DS. The Doctor's Guide to Chronic Fatigue Syndrome. Reading, MA: Addison Wesley, 1995.
  • Saleh D, Ernst P, Lim S, et al. Increased formation of the potent oxidant per-oxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998; 12: 929–937.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.